Go Pro
NASDAQ:ICU

SeaStar Medical (ICU) Stock Price, News & Analysis

SeaStar Medical logo
$3.02 -0.11 (-3.39%)
As of 01:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About SeaStar Medical Stock (NASDAQ:ICU)

Advanced

Key Stats

Today's Range
$3.02
$3.16
50-Day Range
$2.88
$5.08
52-Week Range
$2.07
$12.50
Volume
38,295 shs
Average Volume
110,956 shs
Market Capitalization
$13.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Hold

Company Overview

SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets.

Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.

AI Generated. May Contain Errors.

SeaStar Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

ICU MarketRank™: 

SeaStar Medical scored higher than 66% of companies evaluated by MarketBeat, and ranked 303rd out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SeaStar Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    SeaStar Medical has a consensus price target of $8.00, representing about 164.8% upside from its current price of $3.02.

  • Amount of Analyst Coverage

    SeaStar Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about SeaStar Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for SeaStar Medical are expected to grow in the coming year, from ($3.66) to ($2.09) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SeaStar Medical is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SeaStar Medical is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SeaStar Medical has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about SeaStar Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.53% of the float of SeaStar Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    SeaStar Medical has a short interest ratio ("days to cover") of 2.33, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SeaStar Medical has recently decreased by 9.09%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SeaStar Medical does not currently pay a dividend.

  • Dividend Growth

    SeaStar Medical does not have a long track record of dividend growth.

  • News Sentiment

    SeaStar Medical has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for SeaStar Medical this week, compared to 2 articles on an average week.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $2,452.00 in company stock, which represents 0.0184% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,452.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.70% of the stock of SeaStar Medical is held by insiders.

  • Percentage Held by Institutions

    1.69% of the stock of SeaStar Medical is held by institutions.

  • Read more about SeaStar Medical's insider trading history.
Receive ICU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICU Stock News Headlines

ICU: Continued Revenue Growth for QUELIMMUNE®
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript
See More Headlines

ICU Stock Analysis - Frequently Asked Questions

SeaStar Medical's stock was trading at $2.40 at the beginning of the year. Since then, ICU shares have increased by 26.0% and is now trading at $3.0240.

SeaStar Medical Holding Corporation (NASDAQ:ICU) announced its earnings results on Wednesday, August, 12th. The company reported ($0.91) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.97) by $0.06. The business earned $0.62 million during the quarter, compared to the consensus estimate of $0.49 million. SeaStar Medical had a negative trailing twelve-month return on equity of 162.75% and a negative net margin of 795.51%.
Read the conference call transcript
.

SeaStar Medical's stock reverse split on Monday, January 5th 2026.The 1-10 reverse split was announced on Tuesday, December 23rd 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V).

Company Calendar

Last Earnings
8/12/2026
Today
9/11/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:ICU
CIK
1831868
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+164.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.15 million
Net Margins
-795.51%
Pretax Margin
-795.33%
Return on Equity
-162.75%
Return on Assets
-109.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.89
Quick Ratio
1.87

Sales & Book Value

Annual Sales
$1.23 million
Price / Sales
10.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.75 per share
Price / Book
1.10

Miscellaneous

Outstanding Shares
4,410,000
Free Float
4,376,000
Market Cap
$13.32 million
Optionable
Not Optionable
Beta
-1.05
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:ICU) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners